Pharmaceutical From Standard to Specialist Capsule Formats Hard gelatin, HPMC, inhalation and vaginal formats engineered for every therapeutic need.
Nutraceutical Consumer-Ready Nutraceutical Formats Capsules and branded ingredients built for supplement manufacturers who demand differentiation.
Pharmaceutical CDMO
Accelerating Drug Development
Our Innovaform Accelerator and Tampa facility combine formulation science with scalable manufacturing.
CDMO Partnership
Full-Service Nutraceutical Manufacturing
From concept to market-ready product — your end-to-end nutraceutical development partner.
Applications
Our Story
Partners in Drug Delivery Innovation
A global leader in capsule technologies, committed to advancing pharmaceutical and nutraceutical science.
News & Media
May 28, 2026, 7:00 AM
New peer reviewed research published in Pharmaceutics demonstrates that Lonza Capsugel’s Licaps® DUOCAP® capsule in capsule technology can significantly improve protection and targeted delivery of acid sensitive enzymes in the gastrointestinal (GI) tract
May 20, 2026, 7:00 AM
Lonza Capsugel strengthens global renewable energy strategy by integrating local wind power into hard empty capsule manufacturing operations at its Bornem (BE) site through long term power purchase agreement.
Apr 28, 2021, 3:00 AM
Recently published research shows that Carniking® premix improves lean muscle mass and supports efficient energy expenditure in active dogs
Apr 20, 2021, 11:00 AM
Quote from Martin Sambusini, Associate Director of Innovation, Lonza Capsules & Health Ingredients:“Right now, joint health is a key priority...
Apr 1, 2021, 5:00 AM
Citation de Gordon Bates, président et responsable de la division Small Molecules, Lonza :
Apr 1, 2021, 5:00 AM
Completion of sale of Lonza sites in Ploermel (FR) and Edinburgh (UK)A seamless ownership transfer process remains a priorityA French version of this release is also availableQuote...
Jan 19, 2021, 6:00 AM
Agreement initiates process for future acquisition of Lonza sites in Ploermel (FR) and Edinburgh (UK) allowing NextPharma to broaden technology offering into lipid finished dosage...
Jan 19, 2021, 4:59 AM
Citation de Gordon Bates, président et responsable de la division Small Molecules, Lonza :
Dec 17, 2020, 2:00 PM
Glanbia Performance Nutrition's direct-to-customer division Body&Fit to utilize Lonza's Duocap® capsule technologyBody&Fit plans to launch new products featuring Lonza's...
Oct 22, 2020, 5:00 AM
Investment of CHF85m will expand capsule manufacturing capacity by 30 billion capsules annuallyThe new expansion involves eight global Lonza sitesThe investment aims to address the...